Losers (% change)
Back to dashboard| Company Name | Symbol | Price | Prev. Close | Volume | Change | % Change |
|---|---|---|---|---|---|---|
| Accendra Health, Inc. Common Stock | ACH | 2.535 | 2.800 | 996,079 | -0.26 |
-9.46% |
| American Coastal Insurance Corporation - Common Stock | ACIC | 11.46 | 12.63 | 162,355 | -1.17 |
-9.26% |
| BeLive Holdings - ordinary shares | BLIV | 3.250 | 3.580 | 3,154 | -0.33 |
-9.22% |
| Fenbo Holdings Limited - Class A Ordinary Shares | FEBO | 1.210 | 1.330 | 13,002 | -0.12 |
-9.02% |
| Aldeyra Therapeutics, Inc. - Common Stock | ALDX | 4.715 | 5.180 | 674,551 | -0.46 |
-8.98% |
| Kodiak Sciences Inc - Common Stock | KOD | 25.49 | 27.96 | 630,890 | -2.47 |
-8.83% |
| Enanta Pharmaceuticals, Inc. - Common Stock | ENTA | 14.38 | 15.77 | 254,141 | -1.39 |
-8.81% |
| Neumora Therapeutics, Inc. - Common Stock | NMRA | 1.635 | 1.790 | 1,712,550 | -0.16 |
-8.66% |
| Paymentus Holdings, Inc. Class A Common Stock | PAY | 28.87 | 31.59 | 862,645 | -2.72 |
-8.61% |
| Caesarstone Ltd. - Ordinary Shares | CSTE | 1.700 | 1.860 | 88,128 | -0.16 |
-8.60% |
| Replimune Group, Inc. - Common Stock | REPL | 8.885 | 9.720 | 708,131 | -0.84 |
-8.59% |
| Vanda Pharmaceuticals Inc. - Common Stock | VNDA | 8.065 | 8.820 | 4,263,975 | -0.76 |
-8.56% |
| Envela Corporation Common Stock | ELA | 12.24 | 13.38 | 104,341 | -1.14 |
-8.52% |
| MoonLake Immunotherapeutics - Class A Ordinary Shares | MLTX | 12.06 | 13.18 | 1,447,109 | -1.12 |
-8.50% |
| Kestrel Group, Ltd. - Common Stock | KG | 9.370 | 10.24 | 39,169 | -0.87 |
-8.50% |
| Jyong Biotech Ltd. - Ordinary shares | MENS | 3.619 | 3.950 | 512,605 | -0.33 |
-8.39% |
| Ventyx Biosciences, Inc. - Common Stock | VTYX | 8.280 | 9.030 | 992,183 | -0.75 |
-8.31% |
| Phaos Technology Holdings (Cayman) Limited Class A Ordinary Shares | POAS | 3.146 | 3.430 | 155,338 | -0.28 |
-8.28% |
| Reitar Logtech Holdings Limited - Ordinary shares | RITR | 1.055 | 1.150 | 136,442 | -0.09 |
-8.26% |
| Kyverna Therapeutics, Inc. - Common Stock | KYTX | 8.625 | 9.400 | 1,033,395 | -0.78 |
-8.24% |
| Jade Biosciences, Inc. - Common Stock | JBIO | 14.18 | 15.43 | 163,830 | -1.25 |
-8.10% |
| Lyell Immunopharma, Inc. - Common Stock | LYEL | 28.32 | 30.78 | 95,585 | -2.46 |
-8.01% |
| NextCure, Inc. - Common Stock | NXTC | 13.06 | 14.19 | 41,386 | -1.13 |
-7.96% |
| Cardinal Infrastructure Group Inc. - Class A Common Stock | CDNL | 22.27 | 24.18 | 258,062 | -1.91 |
-7.88% |
| Insight Molecular Diagnostics Inc. - Common Stock | IMDX | 6.910 | 7.500 | 53,367 | -0.59 |
-7.87% |
| Alto Neuroscience, Inc. Common Stock | ANRO | 16.41 | 17.80 | 162,891 | -1.39 |
-7.78% |
| Klaviyo, Inc. Series A Common Stock | KVYO | 29.95 | 32.47 | 2,916,180 | -2.52 |
-7.78% |
| Applovin Corporation - Class A Common Stock | APP | 621.62 | 673.82 | 4,551,171 | -52.20 |
-7.75% |
| Pelthos Therapeutics Inc. Common Stock | PTHS | 28.60 | 31.00 | 18,984 | -2.40 |
-7.74% |
| DarioHealth Corp. - Common Stock | DRIO | 10.50 | 11.38 | 10,940 | -0.88 |
-7.73% |
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.